We investigated the expression of SLC2A3 and ASNS in tumor and normal groups using the R package, and consistently observed high expression levels of SLC2A3 (p = 0.001) and ASNS (p = 2.708e-15) in the tumor group (Fig. 4e-f). This evidence concerns the gene ASNS and neoplasm.